Table 5.
The Bonferroni post-hoc analysis according toantipsychotic drugs
| Comparison | Mean difference | 95% Cl for mean difference | pvalue | ||
|---|---|---|---|---|---|
| Lower | Upper | ||||
| AMSP | BLON | 60.2 | 17.5 | 102.9 | 0.001 |
| OZP | 64.0 | 26.0 | 102.0 | < 0.001 | |
| RPR | 28.9 | −9.2 | 67.0 | 0.265 | |
| BLON | AMSP | −60.2 | −102.9 | −17.5 | 0.001 |
| OZP | 3.8 | −26.1 | 33.8 | 1.000 | |
| RPR | −31.3 | −61.6 | −1.0 | 0.038 | |
| OZP | AMSP | −64.0 | −102.0 | −26.0 | < 0.001 |
| BLON | −3.8 | −33.8 | 26.1 | 1.000 | |
| RPR | −35.1 | −58.0 | −12.3 | < 0.001 | |
| RPR | AMSP | −28.9 | −67.0 | 9.2 | 0.265 |
| BLON | 31.3 | 1.0 | 61.6 | 0.038 | |
| OZP | 35.1 | 12.3 | 58.0 | < 0.001 | |
AMSP, amisulpride; BLON, blonanserin; OZP, olanzapine; RPR, risperidone; CI, confidence interval.